Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Vasculitis 1Prostatic Neoplasms 1Neoplasm Metastasis 1Metabolic Syndrome 1Lung Neoplasms 1Inflammation 1Granulomatosis with Polyangiitis 1Bone Neoplasms 1Arthritis, Juvenile 1

Interventions

sotrovimab 1ciclesonide 1Niclosamide 1Etanercept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Vasculitis × Etanercept × Clear all
NCT00005007 2007-12-28

Etanercept for Wegener's Granulomatosis

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Phase 2/3 Completed
181 enrolled

Vasculitis, Granulomatosis with Polyangiitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡